Video-on-Demand Library

This content is restricted to members of PSI. If you are already a member please login. To join PSI or to see all the benefits of membership click here.

16 June 2024

Rachel Lawrence, Konstantina Skaltsa, John Devin Peipert, Piper Fromy

What does patient focused drug development mean to you as a statistician? PFDD SIG is new and we want to help you. We also want to share some hot topics today – statistical challenges in PRO endpoint analyses, using PROs to effectively demonstrate clinical benefit, navigating regulatory pathways, considerations for using PROs for safety/tolerability and using digital medicine to reflect changes in health that matter to patients.

Part of Collection(s)

Upcoming Events

Latest Jobs